文献
J-GLOBAL ID:201802231547745279
整理番号:18A0269745
治癒切除された膵臓癌患者におけるゲムシタビンと自己γδT細胞移動によるアジュバント併用療法【Powered by NICT】
Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pancreatic cancer
著者 (7件):
Aoki Taku
(Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, The University of Tokyo, Tokyo, Japan)
,
Aoki Taku
(Second Department of Surgery, Dokkyo Medical University, Mibu, Tochigi, Japan)
,
Matsushita Hirokazu
(Department of Immunotherapeutics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan)
,
Hoshikawa Mayumi
(Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, The University of Tokyo, Tokyo, Japan)
,
Hasegawa Kiyoshi
(Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, The University of Tokyo, Tokyo, Japan)
,
Kokudo Norihiro
(Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, The University of Tokyo, Tokyo, Japan)
,
Kakimi Kazuhiro
(Department of Immunotherapeutics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan)
資料名:
Cytotherapy
(Cytotherapy)
巻:
19
号:
4
ページ:
473-485
発行年:
2017年
JST資料番号:
W1781A
ISSN:
1465-3249
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)